TCR2 Therapeutics Inc. buy BiotechBee
Start price
04.02.23
/
50%
€1.31
Target price
04.02.24
€3.00
Performance (%)
34.48%
End price
05.05.23
€1.76
Summary
This prediction ended on 05.05.23 with a price of €1.76. The BUY prediction by BiotechBee for TCR2 Therapeutics Inc. saw massive gains of 34.48%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
TCR2 Therapeutics Inc. | - | - | - |
iShares Core DAX® | -2.926% | -3.811% | 9.621% |
iShares Nasdaq 100 | 4.462% | 7.635% | 33.690% |
iShares Nikkei 225® | 0.306% | -0.065% | 4.201% |
iShares S&P 500 | 2.488% | 4.185% | 27.301% |
According to BiotechBee what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Tcr2 Therapeutics Inc.
Buy beendet